Walleye Trading’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-22,800
| Closed | -$3.92M | – | 6233 |
|
|
2021
Q3 | $3.92M | Buy |
22,800
+21,600
| +1,800% | +$2.83M | 0.01% | 1071 |
|
|
2021
Q2 | $151K | Buy |
1,200
+300
| +33% | +$37.8K | ﹤0.01% | 4150 |
|
|
2021
Q1 | $122K | Buy |
900
+400
| +80% | +$51.7K | ﹤0.01% | 3997 |
|
|
2020
Q4 | $64K | Sell |
500
-19,200
| -97% | -$2.25M | ﹤0.01% | 4108 |
|
|
2020
Q3 | $2.22M | Buy |
19,700
+18,800
| +2,089% | +$1.87M | 0.01% | 1053 |
|
|
2020
Q2 | $86K | Sell |
900
-2,400
| -73% | -$231K | ﹤0.01% | 3591 |
|
|
2020
Q1 | $297K | Sell |
3,300
-2,100
| -39% | -$163K | ﹤0.01% | 2304 |
|
|
2019
Q4 | $286K | Buy |
+5,400
| New | +$246K | ﹤0.01% | 2862 |
|
|
2019
Q3 | – | Sell |
-3,600
| Closed | -$148K | – | 4586 |
|
|
2019
Q2 | $148K | Sell |
3,600
-1,300
| -27% | -$53.8K | ﹤0.01% | 3133 |
|
|
2019
Q1 | $228K | Sell |
4,900
-7,100
| -59% | -$312K | ﹤0.01% | 2927 |
|
|
2018
Q4 | $523K | Buy |
12,000
+200
| +2% | +$9.99K | ﹤0.01% | 2436 |
|
|
2018
Q3 | $675K | Buy |
+11,800
| New | +$580K | ﹤0.01% | 2544 |
|
|
2018
Q2 | – | Sell |
-5,500
| Closed | -$215K | – | 5059 |
|
|
2018
Q1 | $215K | Sell |
5,500
-13,600
| -71% | -$578K | ﹤0.01% | 3439 |
|
|
2017
Q4 | $809 | Buy |
+19,100
| New | +$716K | ﹤0.01% | 2145 |
|
Walleye Trading's XLRN Position: Q4 2021 in Review
Walleye Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 27,259 shares — an estimated $4.69M sold.
Walleye Trading first reported a position in XLRN in Q4 2018 and held it in 7 quarters. The position peaked at $4.69M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Walleye Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Walleye Trading sold 27,259 Acceleron Pharma shares in Q4 2021, an estimated $4.69M.
- Walleye Trading first reported a position in Acceleron Pharma in Q4 2018 and held it in 7 quarters.
- Walleye Trading's Acceleron Pharma position peaked at $4.69M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.